Clinical trials recruiting for Non-Melanoma Skin Cancer (NMSC)
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Ameluz 10% Topical Gel | 1 |
| Dabrafenib | 1 |
| Nicotinamide | 1 |
| Trametinib | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New Hampshire | 1 |
| Utah | 1 |
Top cities
Self-screener
Recruiting trials
- Assessment of Skin Lesions Using a Tissue Oxygen Imager Based on Protoporphyrin IX (PPIX) Fluorescence. This is an Open-label, Non-randomized, Feasibility Study That Includes a One-time Application of an FDA Approved Medication Followed by Local Imaging for Benign Skin Growth and Lesions Clinically
- DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
- Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
Related conditions
Trials recruiting for Non-Melanoma Skin Cancer (NMSC) often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Non-Melanoma Skin Cancer (NMSC) trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.